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Abstract The NADH:ubiquinone reductase (NDH-2) of Es-
cherichia coli was expressed as a His-tagged protein, extracted
from the membrane fraction using detergent and purified by
chromatography. The His-tagged NDH-2 was highly active and
catalyzed NADH oxidation by ubiquinone-1 at rates over two
orders of magnitude higher than previously reported. The
purified, His-tagged NDH-2, like native NDH-2, did not oxidize
deamino-NADH. Steady-state kinetics were used to analyze the
enzyme’s activity in the presence of different electron acceptors.
High Vmax and low Km values were only found for hydrophobic
ubiquinone analogues, particularly ubiquinone-2. These findings
strongly support the notion that NDH-2 is a membrane bound
enzyme, despite the absence of predicted transmembrane
segments in its primary structure. The latter observation is in
agreement with possible evolutionary relation between NDH-2
and water-soluble enzymes such as dihydrolipoamide dehydro-
genase. There is currently no clear indication of how NDH-2
binds to biological membranes.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
The respiratory NADH dehydrogenase of Escherichia coli,
the product of the ndh gene, was ¢rst puri¢ed and partially
characterized about 20 years ago [1^3]. It was then considered
to be the sole NADH:quinone reductase of E. coli, but it was
later discovered that the bacterium also has a Complex I-type
NADH dehydrogenase [4]. The bacterial Complex I is often
called NDH-1, and the ‘alternative’ enzyme that does not
pump protons across the membrane and does not oxidize
deamino-NADH is called NDH-2 [4]. NDH-1 is a multi sub-
unit, H-translocating NADH:quinone reductase that con-
tains FMN and many iron-sulfur clusters [5]. NDH-2, on
the other hand, contains neither Fe^S clusters nor FMN,
and its sole redox center is the £avin cofactor FAD [1^3,6].
NDH-2 was not detected in animal mitochondria, but sim-
ilar enzymes are present in fungi mitochondria. In Saccharo-
myces cerevisiae, a fungus that lacks Complex I, there is at
least one NDH-2 that faces the mitochondrial matrix, and
another one that faces the cytoplasmic side of the inner mem-
brane, i.e. the inter-membrane space [7]. Yarrowia lipolytica is
a fungus that has Complex I and also expresses an outward
facing NDH-2 [8]. An NDH-2 with a putative Ca binding site
was recently characterized in mitochondria of Neurospora
crassa, another Complex I-containing fungus [9].
Paracoccus denitri¢cans is a soil bacterium that has NDH-1,
but no NDH-2. In order to enable genetic inactivation of this
NDH-1, the ndh gene of E. coli was inserted into the nqo8
gene of P. denitri¢cans, leading to the expression of an active
and membrane bound NDH-2 in P. denitri¢cans [10]. In the
course of that work, it was noticed that the ndh gene product
lacks predicted transmembrane segments, and the question
how this membrane protein binds to biological membrane
was raised. One segment of this protein, from L242 to
T247, was previously suggested to bind to the membrane
[10]. However, when more NDH-2 sequences became avail-
able, it turned out that this segment is not highly conserved,
thus rendering that suggestion less likely.
The puri¢ed NDH-2, as originally prepared, was almost
inactive. Its activity was somewhat improved by the addition
of FAD to the reaction mixture, but it was still very low [1,2].
It might be speculated that both the low activity and the
absence of predicted transmembrane helices in NDH-2 stem
from the loss of a not yet discovered second subunit. Perhaps
native NDH-2 is made of two subunits, only one of which is
encoded by ndh, and the other one is involved in binding to
the membrane. At present, however, there is no evidence that
NDH-2 contains another protein in addition to the ndh gene
product.
If NDH-2 is indeed a single-subunit NADH:ubiquinone
reductase, it may serve as an interesting model system for
studies on ubiquinone binding sites, and on protein interac-
tions with biological membranes. In order to gain insight into
the structure and function of NDH-2, one must develop a
puri¢cation method that yields highly active enzyme in con-
siderable amounts. To this end, we have expressed the ndh
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gene in E. coli as a His-tagged protein and puri¢ed the enzyme
in the presence of mild detergent. The e¡ect of the induced
expression on the morphology of the cells was examined, and
the activity of the puri¢ed enzyme was analyzed. The results
are described and discussed below.
2. Materials and methods
2.1. Materials
Ubiquinone-1 (Q1) was a generous gift from Hofmann-La Roche,
Switzerland; ubiquinone-2 (Q2) was a generous gift from Eisai, Ja-
pan; hydroxidecyl benzoquinone (Idebenone) was a generous gift
from Dr. Degli Esposti, Monash University; decylubiquinone (DB)
and deamino-NADH were purchased from Sigma. NADH was pur-
chased from Boehringer, dodecyl sucrose (DS) was from Novabio-
chem, and dodecyl maltoside (DM) from Anatrace.
2.2. Cloning and expression of His-tagged NDH-2
The ndh gene [3] was ampli¢ed from genomic DNA, using a for-
ward primer that contained a BglII site downstream the ¢rst codon of
the gene, and a reverse primer that contained an XhoI site immedi-
ately downstream the stop codon. The ampli¢ed DNA was digested
by BglII and XhoI and ligated into the expression plasmid pQE-31
(Qiagen) that was digested with BamHI and SalI. The resultant cloned
ndh encodes NDH-2 with an N-terminal extension of 13 amino acids,
MRGSHHHHHHTDL. The plasmid was named pHN3, and it was
used to transformed E. coli XL1 cells (Stratagene). Cells carrying
pHN3 were named HN3-XL1. Induced expression of His-tagged
NDH-2 was done in LB medium (1 l in a 2.5 l bottle) that was inoc-
ulated with 20 ml of overnight culture of HN3-XL1, and placed on a
shaker (200 rpm) at 37‡C. About 3 h after inoculation, the cells
reached the early log phase and NDH-2 expression was initiated by
the addition of isopropylthio-L-D-galactoside (IPTG, 0.5 mM). The
cells were harvested 2 h after induction, washed with a solution con-
taining 500 mM KCl, 10 mM Tris^Cl, pH 7.5, 0.2 mM phenylmeth-
ylsulfonyl £uoride (PMSF) and stored at 320‡C.
2.3. Membrane isolation
Cells were thawed on ice and suspended in 2.5 mM EDTA, 0.2 mM
PMSF, 200 mM Tris^Cl, pH 8.0, to about 1 g per 10 ml. Lysozyme
was added and the mixture was stirred for 1 h on ice. The suspension
was centrifuged at 120 000Ug for 60 min. The pellet was subjected to
osmotic shock by suspension in 10 mM potassium phosphate, 2 mM
EDTA, 0.2 mM PMSF, pH 8.0, and vigorous mixing by a tissue
homogenizer (Ultra Turrax), followed by a second ultracentrifuga-
tion. The membrane fraction was homogenized in 10 mM potassium
phosphate, 2 mM EDTA, 0.2 mM PMSF, pH 8.0, and stored at
380‡C.
2.4. A⁄nity puri¢cation of His-tagged NDH-2
Membranes were thawed on ice and extracted by the addition of
detergent, either DS or DM, to a ¢nal concentration of 0.2% (w/v),
and a detergent to a protein weight ratio of 0.1. NaCl was added to a
¢nal concentration of 500 mM, and the suspension was mixed well, on
ice, for 30 min followed by 60 min centrifugation at 120 000Ug. His-
tagged NDH-2 was puri¢ed from the detergent extract of the mem-
branes by metal-chelating chromatography using Ni-NTA resin (Qia-
gen) at 4‡C. The column (1 ml per 0.5 mg protein in the supernatant)
was pre-equilibrated with bu¡er containing 50 mM potassium phos-
phate, pH 7.5, 500 mM NaCl, 0.2% (w/v) DS or DM, and 20 mM
imidazole (bu¡er A). After loading the sample, the column was
washed with two column volumes of bu¡er A, followed by a wash
of a similar volume of 50 mM Tris^Cl, pH 7.5, 0.2% (w/v) DS or DM
(bu¡er B) and then with one column volume of 50 mM Tris^Cl, pH
7.5, 0.2% (w/v) DS or DM, and 10 mM CaCl2 (bu¡er C). After this
‘calcium wash’, the column was washed again with three volumes of
bu¡er B and two column volumes of bu¡er A. The bound NDH-2
was then eluted using an imidazole gradient in the presence of 500
mM NaCl and 50 mM potassium phosphate, pH 7.5. His-tagged
NDH-2 eluted from the column at about 200 mM imidazole, and
was concentrated to about 2 mg/ml using either a ‘centricon’ or a
‘centriprep’ system (Amicon) with a pore size of 50 kDa. Glycerol
was added to a ¢nal concentration of 20% (v/v), and the enzyme
was stored at 380‡C.
2.5. Activity assays
The enzymatic activity of puri¢ed His-tagged NDH-2 was measured
spectrophotometrically. The puri¢ed enzyme was thawed and diluted
to 40 Wg protein/ml in a solution containing 12 mg/ml sonicated phos-
pholipid (6 mg/ml soybean and 6 mg/ml E. coli phospholipid), 150
mM NaCl, 50 mM potassium phosphate, pH 7.5. The diluted enzyme
was placed on ice for 10 min followed by a 10-fold dilution (second
dilution) using the same phospholipid-containing solution, and kept
on ice for 20 min (and no longer than 3 h) before the assays that were
carried out at 30‡C in a ¢nal volume of 1 ml. The enzyme (10 Wl from
the second dilution mixture) was added into the bu¡er (50 mM po-
tassium phosphate, pH 7.5, 30‡C), followed by the addition of accep-
tor to the desired concentration. After 3 min incubation at 30‡C, the
reaction was started by the addition of NADH. The substrate con-
centration was measured spectrophotometrically using the following
extinction coe⁄cients (mM31, cm31) : NADH, 6.2 at 340 nm; Q1 and
Q2, 13.7 at 275 nm; DB, 14.0 at 278 nm; duroquinone, 19.2 at 270
nm; ferricyanide, 1.0 at 420 nm; dichlorophenolindophenol (DCIP),
22.0 at 600 nm.
3. Results and discussion
NDH-2 of E. coli is an interesting enzyme, particularly for
studies on ubiquinone reduction sites and the interactions of
proteins with biological membranes. The enzyme was ¢rst
puri¢ed and partially characterized about 20 years ago, and
found to contain FAD but no Fe^S clusters or hemes [1^3].
Unfortunately, the activity of the enzyme, as originally puri-
¢ed, was poor, thus severely limiting further studies on its
structure and function. In order to overcome this problem,
we have designed a new puri¢cation protocol, taking advant-
age of tools that were not available at the time of the previous
puri¢cation, e.g. the addition of an a⁄nity tag to the N-ter-
minus of the protein.
A glycine-rich sequence motif is present very near the N-
terminus of NDH-2 [3]. This segment is probably involved in
binding the ADP part of the FAD cofactor ([7] and see below)
and its N-terminal location might render the bound £avin
more susceptible to dissociation during puri¢cation, as report-
edly occurred in the past [1,2]. Due to the proximity of the
FAD binding site to the N-terminus, the addition of a 13
amino acid extension at this end of the protein might interfere
with FAD insertion into the enzyme. However, if assembly
was una¡ected, the additional stretch of amino acids could
contribute positively to the stability of the enzyme during
puri¢cation. The high speci¢c activity of the puri¢ed His-
tagged NDH-2 (Table 1) demonstrates that the N-terminal
extension did not prevent correct FAD binding to the enzyme.
The expression of His-tagged NDH-2 was induced by the
addition of IPTG to a culture of HN3-XL1 cells at the early
logarithmic growth phase. The induced cells had a pale green
color that was not seen in the control cells that harbor the
pQE-31 plasmid without any insert. The membranes fraction
of induced HN3-XL1 cells, i.e. the top layer of the pellet after
ultracentrifugation of lysozyme-treated and osmotically dis-
rupted cells, had a distinct yellowish color. The greenish color
of the harvested cells and the yellowish color of the mem-
brane, as well as the absence of a large fraction of inclusion
bodies, suggested that the expression of His-tagged NDH-2
was both high and e⁄cient.
Detergents play a major role in puri¢cation of integral
membrane proteins. In the previous NDH-2 puri¢cation, the
membranes were solubilized using high concentrations of
cholate (3% in the presence of 1 M KCl). That solubilization
was followed by chromatography on hydroxylapatite in the
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presence of merely 0.1% cholate at very low ionic strength [1].
In the present work, DM (or DS, a practically identical de-
tergent as far as this puri¢cation is concerned) was used. In
addition, we took care not to lower the detergent concentra-
tion below its critical micellar concentration (cmc), as might
have happened during the chromatography step in the pre-
vious works [1,2].
His-tagged NDH-2 was puri¢ed by metal-chelating chroma-
tography in the presence of detergent. Bound enzyme was
thoroughly washed and then eluted by an imidazole gradient
in the presence of high ionic strength (Fig. 1). The fractions
exhibiting high NADH:Q1 reductase activity were immedi-
ately pooled, concentrated and, after addition of glycerol,
stored at 380‡. Sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE) analysis of the pooled fractions
shows a single band, the Mr of which is, as expected, about 47
kDa (Fig. 1).
The NADH:Q1 reductase activity of the puri¢ed NDH-2,
after dilution and incubation in the presence of sonicated
phospholipid, was very high (Table 1). For comparison, the
activity of the previously puri¢ed enzyme was about 0.5 mmol
NADH oxidized per min per mg protein, and in the present
case, it was about 100 mmol NADH per min per mg protein
(Table 1). The reasons for this dramatic di¡erence in speci¢c
activity are not fully clear. It may partly be due to the di¡er-
ences in either the detergent used during solubilization and
puri¢cation, the chromatography step, or the storage of the
puri¢ed enzyme. We have noticed that activity declines rap-
idly if the NDH-2 is not concentrated soon after chromatog-
raphy and stored at 380‡C in the presence of glycerol and
high ionic strength. In addition, part of the di¡erence in spe-
ci¢c activity may be due to improvements in the assay con-
ditions, and in the preparation of the enzyme for the assay,
i.e. the dilution and pre-incubation in the presence of phos-
pholipid. In any case, the high activity of the puri¢ed His-
tagged NDH-2 indicates that the ndh gene product is the sole
protein component of this enzyme.
The Km and Vmax values for the reaction of NDH-2 with
NADH were determined (Table 1). The acceptor in these ex-
periments was Q1, and the apparent Km for NADH was about
half the value determined previously [1]. No turnover was
detected when deamino-NADH was the electron donor. The
latter is in full agreement with the substrate speci¢city of the
unmodi¢ed enzyme in the native membrane [4], and these
results suggest that the NADH binding site of the His-tagged
NDH-2 is very similar to the donor binding site in native
NDH-2.
In studies on Complex I and subcomplexes that were iso-
lated from it, we have found that the turnover rate of the
intact enzyme in the presence of DB was higher than with
Q1. In contrast, subcomplexes IV and IS that lack several of
Table 1
Kinetic parameters for the activity of NDH-2 in the presence of dif-
ferent substrates
Km
(apparent,
WM)
Vmax
(mmol NADH/mg
protein/min)
NADHa (Q1 reduction) 34 106
Qb1 5.9 106
Qb2 2.3 190
DBb 18.7 191
Idebenoneb 1.8 107
Duroquinoneb n.d. 5.5
Ferricyanideb n.d. 6.5
DCIPb 20 19.5
aIn measurements of the Km and Vmax for NADH, the acceptor was
45 WM Q1.
bThe NADH concentration in the assays for di¡erent electron ac-
ceptors was 0.15 mM.
Fig. 1. Puri¢cation of His-tagged NDH-2 by metal-chelating chromatography. Solubilized NDH-2 was loaded onto the column, washed well
and eluted using an imidazole gradient in the presence of 500 mM NaCl and 0.1% DM. The chromatogram shown here starts after the washes
(see Section 2) and the imidazole gradient is indicated by the dashed line. It may be noted that imidazole contributes to the absorbance at 280
nm. The fraction eluted at about 200 mM imidazole contained the His-tagged NDH-2. An SDS^PAGE analysis (10^20% acrylamide gradient)
of a pool of these fractions is shown on the left. 10 Wg His-tagged NDH-2 was loaded on the gel and it was stained with Coomassie blue.
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the integral membrane subunits of Complex I were almost
inactive in the presence of DB, but reduced Q1 at similar rates
to that of intact Complex I [11]. These results may suggest
that high NADH:Q1 reductase activity by itself is not su⁄-
cient evidence that the entire integral membrane part of the
enzyme is present in the puri¢ed NDH-2. Considering that the
physiological electron acceptor for NDH-2 in E. coli mem-
branes is ubiquinone-8, it was interesting to measure the ac-
tivity of the puri¢ed enzyme in the presence of more hydro-
phobic acceptors than Q1. Q2 is an inhibitor of the
mitochondrial Complex I, but with bacterial NDH-1 from
P. denitri¢cans, it exhibits similar properties to Q1 [12]. The
Vmax of the latter bacterial NDH-1 in the presence of DB is
very similar to that in the presence of Q1 or Q2, but the Km
for DB is higher than for the quinone analogues that side
chain of which is isoprenoid [12]. In light of these results
with mitochondrial Complex I, some of its subcomplexes,
and P. denitri¢cans NDH-1, it was interesting to examine
the activity of NDH-2 in the presence of ubiquinone ana-
logues that are more hydrophobic than Q1.
The activity of puri¢ed NDH-2 was examined in the pres-
ence of several electron acceptors. In all cases where a signi¢-
cant turnover rate was detected, the steady-state kinetics of
the reaction were analyzed, as shown for Q1, Idebenone and
DB (Fig. 2). The Km and Vmax values that were derived from
such titrations are summarized in Table 1. One of the clear
outcomes of these experiments is the high Vmax of NDH-2 in
the presence of all the hydrophobic quinone analogues that
were used in this work, namely Q1, Q2, DB and Idebenone. In
particular, the high Vmax/Km ratio for Q2 (Table 1) indicates
that this is a very good electron acceptor for NDH-2 of E.
coli.
Idebenone is an inhibitor of mitochondrial Complex I [13],
and we have initially examined its potency as an inhibitor of
the Q1 reductase activity of NDH-2. It soon became clear,
however, that Idebenone is a better acceptor for NDH-2
than Q1 (Fig. 2 and Table 1). It may be noted that Idebenone
also functions as an electron acceptor in the case of the mi-
tochondrial succinate:ubiquinone reductase (Complex II) [13].
In addition to hydrophobic ubiquinone analogues, we have
also examined the kinetic properties of several water-soluble
acceptors. The turnover rate of NDH-2 with the water-soluble
quinone analogue duroquinone was very low, as was the ac-
tivity in the presence of the single electron acceptor ferricya-
nide (Table 1). DCIP is a slightly better acceptor than either
duroquinone or ferricyanide, but in comparison to the hydro-
phobic quinones that were examined in this study, it is also a
poor acceptor for NDH-2 (Table 1). It thus appears that the
quinone reduction site of NDH-2 is not easily accessible for
water-soluble acceptors. These results also demonstrate that
NDH-2 does not exhibit a typical diaphorase activity. This
does not exclude, however, evolutionary relationships between
NDH-2 and diaphorases such as lipoamide dehydrogenase
(see below).
The homology between E. coli NDH-2 and similar enzymes
in fungi has been analyzed elsewhere, and a detailed alignment
of the putative FAD and NADH binding segments in NDH-2
can be found in [7]. It has recently been reported that the p64
protein of N. crassa is homologous to the NDH-2-like en-
zymes of S. cerevisiae, with the exception that it contains an
additional internal segment of about 85 amino acids that in-
cludes a Ca binding motif [8]. Such a domain is not present in
NDH-2 of E. coli (not shown).
Alignments of NDH-2-like enzymes from di¡erent organ-
isms may indicate which amino acids in these proteins are
conserved and thus might play a role in their structure or
function [7,8]. Nevertheless, until now, knowledge about the
structure and function of NDH-2-like enzyme has been scarce,
hence the information that can be derived from such align-
ments is limited. Due to this, we have tried to identify either
£avoproteins or NAD(P)H oxidoreductases among the pro-
teins of low homology to NDH-2 in a regular GenBank
search, and examine them carefully. Such a search strategy
revealed that NDH-2 may be related to lipoamide dehydro-
genase (Fig. 3) and other members of the FAD-dependent
Fig. 2. Kinetic analyses of the NADH:quinone reductase activity of
His-tagged NDH-2 in the presence of Q1, Idebenone and DB. The
titrations were carried out after short incubation of the puri¢ed en-
zyme in the presence of sonicated phospholipid (see Section 2). Sol-
id lines represent best ¢ts according to the Michaelis^Menten equa-
tion.
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NAD(P)H-(disul¢de)-oxidoredeductase protein family. The
members of this family are water-soluble FAD-containing en-
zymes that have a pair of highly conserved cysteine residues
that form a disul¢de bridge that may be reduced by
NAD(P)H [14,15].
An alignment of NDH-2 with lipoamide dehydrogenase
from two bacteria, Pseudomonas putida and Azotobacter vine-
landii, is shown in Fig. 3. The three-dimensional structures of
these two lipoamide dehydrogenases have been solved by X-
ray crystallography [16,17], and thus may be useful in future
studies on NDH-2. The homology between NDH-2 and lipo-
amide dehydrogenases is high at the protein regions that are
involved in binding FAD and NADH, e.g. the ¢rst 30 amino
acids, and the segments between amino acids 175^186, 210^
240 and 297^317 (ndh sequence) (Fig. 3). A interesting excep-
tion to the similarity between NDH-2 and lipoamide dehydro-
genase is the absence of the conserved cysteine pair in NDH-
2. These cysteines (marked by asterisks in Fig. 3) are one of
the major hallmarks of the FAD-dependent NAD(P)H-(disul-
¢de)-oxidoredeductases protein family. Nevertheless, the sim-
ilarity between NDH-2 and members of this protein family
may be signi¢cant since in addition to sequence homology it
also includes non-covalently bound FAD and NAD(P) or
NAD(P)H as a substrate of the enzyme. It may thus be sug-
gested that NDH-2 shares a distant common ancestor with
members of the FAD-dependent NAD(P)H-(disul¢de)-oxido-
redeductases protein family.
The homology between NDH-2 and lipoamide dehydrogen-
ase, a water-soluble enzyme, raises again the question how
NDH-2 binds to biological membranes. We have not yet
Fig. 3. Sequence alignments of NDH-2 of E. coli (ndh) with lipoamide dehydrogenase from P. putida (DLD1) and A. vinelandii (DLDH). Ac-
cession numbers for the genes used in this ¢gure are: ndh, P00393; DLD1, P09063; DLDH, P18925. The two highly conserved cysteines in
members of the FAD-dependent NAD(P)H-(disul¢de)-oxidoredeductases protein family are marked by asterisks.
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found the answer to this question. Nevertheless, it is hoped
that the availability of a large amount of pure and active
NDH-2 (Figs. 1, 2 and Table 1) will be instrumental in ad-
dressing this as well as other questions about the structure
and catalytic mechanism of NDH-2.
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